IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,445,987 | +205.9% | 3,814,691 | +51.1% | 4.88% | +252.5% |
| Q2 2023 | $47,876,164 | +138.9% | 2,523,783 | +95.4% | 1.39% | +134.1% |
| Q1 2023 | $20,036,718 | +652.6% | 1,291,858 | +761.2% | 0.59% | +689.3% |
| Q4 2022 | $2,662,500 | -95.9% | 150,000 | -89.3% | 0.08% | -89.2% |
| Q4 2020 | $64,666,000 | +31.3% | 1,400,000 | 0.0% | 0.69% | -3.5% |
| Q3 2020 | $49,266,000 | +83.9% | 1,400,000 | +27.3% | 0.72% | +65.7% |
| Q2 2020 | $26,785,000 | – | 1,100,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |